81 Questions
Which statement about tenecteplase is accurate?
It has increased fibrin specificity compared to t-PA
What distinguishes reteplase from streptokinase and t-PA?
It has longer half-life and increased fibrin specificity
What is the role of protamine in anticoagulation?
It reverses the effects of heparin
How does tenecteplase compare to t-PA in terms of bleeding risk?
Similar (and possibly decreased) risk of bleeding
What allows tenecteplase to be administered as a single weight-based bolus?
Its longer half-life
How is reteplase administered?
As a double bolus
Which adverse effect is associated with ticlopidine?
Aplastic anemia
What is the primary clinical use of clopidogrel?
Secondary prevention of atherosclerotic events
Which platelet inhibitor is a reversible inhibitor of the P2Y12 ADP receptor?
Ticagrelor
What is the mechanism of action of GPIIb-IIIa antagonists?
Prevent binding of fibrinogen and other adhesion ligands
What is the primary use of prasugrel?
Acute coronary syndromes with percutaneous coronary intervention
Which adverse effect is associated with eptifibatide?
Major bleeding
Which medication is a competitive inhibitor of protease-activated receptor 1 (PAR-1)?
Vorapaxar
Which medication is an indirect inhibitor of factor Xa with negligible anti-thrombin activity?
Fondaparinux
Which medication has many contraindications and inhibits hepatic epoxide reductase?
Warfarin
Which type of heparin is used for open-heart surgery and disseminated intravascular coagulation?
Unfractionated heparin
Which medication is a selective Factor Xa Inhibitor used for prophylaxis and treatment of deep vein thrombosis and pulmonary embolism?
Fondaparinux
Which medication has a higher incidence of heparin-induced thrombocytopenia?
Unfractionated heparin
Which agent is ineffective against fondaparinux?
Protamine
Which agent inhibits serine proteases plasmin, t-PA, and thrombin, but may increase the risk of postoperative acute renal failure and fatal anaphylactic reactions?
Aprotinin
Which agents are lysine analogues that inhibit plasminogen and plasmin, used to reduce perioperative bleeding during coronary artery bypass grafting without increasing the risk of postoperative acute renal failure?
Aminocaproic acid and tranexamic acid
What do antiplatelet agents primarily interfere with?
Platelet adhesion, release reaction, and aggregation
What do anticoagulants primarily target?
Plasma coagulation factors
What do thrombolytic agents mediate?
Clot dissolution by promoting the conversion of plasminogen to plasmin
Which of the following is a shared adverse effect of Apixaban and Rivaroxaban?
Hematoma
How often is Apixaban administered?
Twice daily
Which thrombolytic agent is used for ST elevation myocardial infarction and deep vein thrombosis?
Streptokinase
What is the primary use of recombinant activated protein C (r-APC)?
Severe sepsis with organ dysfunction and high risk of death
Which thrombolytic agent is a genetically engineered variant of t-PA with increased specificity for fibrin?
Tenecteplase
What is the primary indication for dabigatran?
Prevention of thromboembolism in non-valvular atrial fibrillation
What distinguishes tenecteplase from t-PA?
Increased fibrin specificity and resistance to plasminogen activator inhibitor 1
What is a distinguishing feature of reteplase compared to streptokinase and t-PA?
Longer half-life and increased specificity for fibrin
What is the primary role of protamine in anticoagulation?
To reverse the effects of heparin in life-threatening hemorrhage
How is reteplase administered?
As a 'double bolus' (two boluses, 30 minutes apart)
Which of the following is a potential adverse effect of direct thrombin inhibitors?
Cerebral ischemia
What is the primary use of Argatroban?
Coronary artery thrombosis
Which thrombolytic agent is used for acute cerebrovascular thrombosis?
Alteplase
What distinguishes tenecteplase and reteplase from streptokinase and t-PA?
Higher specificity for fibrin
Which medication is used for prophylaxis against deep vein thrombosis and anticoagulation in patients undergoing coronary angiography and angioplasty?
Lepirudin
What is the primary use of recombinant activated protein C (r-APC)?
Severe sepsis with organ dysfunction
Which medication is associated with anaphylactoid reactions and stroke as potential adverse effects?
Streptokinase
What is the primary indication for dabigatran?
Non-valvular atrial fibrillation
How is apixaban administered?
Twice daily
What is a potential adverse effect of rivaroxaban?
Gastrointestinal bleeding
What distinguishes recombinant tissue plasminogen activator (t-PA) from tenecteplase and reteplase?
Increased risk of intracranial hemorrhage
Which agent is used for prevention of thromboembolism in non-valvular atrial fibrillation?
Dabigatran
Which factor Xa inhibitor has negligible anti-thrombin (anti-IIa) activity?
Fondaparinux
What is the primary clinical use of Vorapaxar?
Prevention of myocardial infarction, stroke, and cardiovascular death
Which medication is an indirect inhibitor of factor Xa with specific indications for prophylaxis and treatment of deep vein thrombosis and pulmonary embolism?
Fondaparinux
Which anticoagulant is used for various conditions, including open-heart surgery and disseminated intravascular coagulation?
Unfractionated heparin
Which anticoagulant has selective inactivation mechanisms that differ from low-molecular-weight heparins?
Unfractionated heparin
Which anticoagulant is a competitive inhibitor of protease-activated receptor 1 (PAR-1)?
Vorapaxar
Which anticoagulant has specific contraindications and should be avoided in certain conditions?
Fondaparinux
Which anticoagulant inhibits hepatic epoxide reductase and has many contraindications?
Warfarin
Which anticoagulant is used for specific indications and has its own adverse effects, including drug–drug interactions that must be carefully considered?
Low-molecular-weight heparins
Which anticoagulant has a higher incidence of heparin-induced thrombocytopenia compared to low-molecular-weight heparins?
Unfractionated heparin
Which anticoagulant is a selective Factor Xa Inhibitor used for prophylaxis and treatment of deep vein thrombosis and pulmonary embolism?
Fondaparinux
Which anticoagulant must be carefully considered for drug–drug interactions, especially with albumin-bound drugs and those that induce and/or compete for P450 metabolism?
Warfarin
What is the primary role of aprotinin in hemostasis?
Inhibiting plasminogen and plasmin
What is the primary mechanism of action of aminocaproic acid and tranexamic acid?
Inhibiting plasminogen and plasmin
What distinguishes hemostasis from pathologic thrombosis?
Response to vascular injury
What is the primary target of antiplatelet agents?
Platelet adhesion
What is the primary target of anticoagulants?
Coagulation factors
What is the primary mechanism of action of thrombolytic agents?
Mediating clot dissolution
What is a potential limitation of virtually every antithrombotic and thrombolytic agent?
Mechanism-based toxicity of bleeding
What is the potential benefit of pharmacogenomic techniques in the field of hemostasis and thrombosis?
Identifying genetic risk of thrombosis
What remains an opportunity for the development of therapies in hemostasis and thrombosis?
Targeting unexploited components of hemostasis
What will be critical for optimizing the indications, dose, and duration of treatment for new drugs and drug combinations in this field?
Clinical trials
What is the potential role of aspirin and warfarin in the field of hemostasis and thrombosis?
Orally bioavailable and inexpensive
What is a likely challenge for new agents under development in the field of hemostasis and thrombosis?
Mechanism-based toxicity of bleeding
Which adverse effect is associated with ticlopidine?
Aplastic anemia
What is the primary use of clopidogrel?
Secondary prevention of atherosclerotic events
What is the mechanism of action of GPIIb-IIIa antagonists?
Prevent binding of fibrinogen and other adhesion ligands
What is the primary use of prasugrel?
Acute coronary syndromes with percutaneous coronary intervention
Which adverse effect is associated with eptifibatide?
Major bleeding
What is the primary use of ticagrelor?
Acute coronary syndromes and percutaneous coronary intervention
Which adverse effect is associated with abciximab?
Thrombocytopenia
What is the primary use of dipyridamole?
Prophylaxis against thromboembolic disorders
What is the primary use of ticlopidine?
Prophylaxis against thromboembolic disorders
What is the primary use of ticlopidine?
Prophylaxis against thromboembolic disorders
What is the primary use of ticlopidine?
Prophylaxis against thromboembolic disorders
Study Notes
Anticoagulant and Thrombolytic Agents: Key Points
- Apixaban and Rivaroxaban are used for different indications including prevention of thromboembolism and treatment of deep vein thrombosis and pulmonary embolism.
- Both drugs have shared adverse effects such as hematoma, hemorrhage, and severe hypersensitivity reactions.
- Apixaban is administered twice daily, while rivaroxaban is administered once daily.
- Direct thrombin inhibitors include lepirudin, desirudin, and bivalirudin, and are used for prophylaxis against deep vein thrombosis and anticoagulation in patients undergoing coronary angiography and angioplasty.
- These inhibitors have adverse effects like hemorrhage, cerebral ischemia, and peripheral nerve paralysis.
- Argatroban is used for coronary artery thrombosis and prophylaxis in percutaneous coronary intervention, and can cause gastrointestinal, intracranial, and genitourinary tract hemorrhage.
- Dabigatran is used for prevention of thromboembolism in non-valvular atrial fibrillation and treatment of deep vein thrombosis and pulmonary embolism.
- Recombinant activated protein C (r-APC) is used for severe sepsis with organ dysfunction and high risk of death, but is associated with hemorrhage and contraindications such as intracranial mass and recent intracranial surgery.
- Streptokinase is used for ST elevation myocardial infarction and deep vein thrombosis, but can cause major bleeding and intracranial hemorrhage.
- Recombinant tissue plasminogen activator (t-PA) (Alteplase) is used for acute myocardial infarction, acute cerebrovascular thrombosis, and pulmonary embolism, and can cause intracranial hemorrhage and sepsis.
- Tenecteplase and reteplase are genetically engineered variants of t-PA with increased specificity for fibrin and cause adverse effects such as gastrointestinal and intracranial hemorrhage.
- These thrombolytic agents have potential contraindications and adverse effects, including anaphylactoid reactions and stroke.
Pharmacology of Hemostasis and Thrombosis
- Protamine is effective against large unfractionated heparin molecules and can partially reverse the anticoagulant effects of low-molecular-weight heparins, but it is inactive against fondaparinux.
- Aprotinin inhibits serine proteases plasmin, t-PA, and thrombin, promoting clot stabilization, but may increase the risk of postoperative acute renal failure and fatal anaphylactic reactions.
- Aminocaproic acid and tranexamic acid are lysine analogues that inhibit plasminogen and plasmin, used to reduce perioperative bleeding during coronary artery bypass grafting without increasing the risk of postoperative acute renal failure.
- Hemostasis regulates blood fluidity and forms stable fibrin-based clots in response to vascular injury, while pathologic thrombosis results from endothelial injury, abnormal blood flow, and hypercoagulability.
- Antiplatelet agents interfere with platelet adhesion, release reaction, and aggregation, providing prophylaxis against thrombosis in susceptible individuals.
- Anticoagulants primarily target plasma coagulation factors and disrupt the coagulation cascade by inhibiting crucial intermediates.
- Thrombolytic agents mediate clot dissolution by promoting the conversion of plasminogen to plasmin.
- Effective, orally bioavailable, and inexpensive therapeutic agents like aspirin and warfarin are already available for many clinical indications in this field.
- Virtually every antithrombotic and thrombolytic agent is associated with the mechanism-based toxicity of bleeding, which is likely to plague new agents under development.
- Pharmacogenomic techniques may identify individuals with an increased genetic risk of thrombosis who may benefit from long-term antithrombotic treatment.
- Opportunities remain for the development of safer and more effective antiplatelet, anticoagulant, and thrombolytic therapies, including new agents targeting unexploited components of hemostasis.
- Carefully designed clinical trials will be critical to optimize the indications, dose, and duration of treatment for new drugs and drug combinations.
Platelet Inhibitors: Mechanisms and Clinical Considerations
- Phosphodiesterase inhibitors like dipyridamole inhibit platelet cAMP degradation, used for prophylaxis against thromboembolic disorders and as an alternative in thallium myocardial perfusion imaging.
- Dipyridamole adverse effects include exacerbation of angina, liver failure, stroke, and rare bronchospasm.
- Ticlopidine, clopidogrel, prasugrel, and ticagrelor are ADP receptor pathway inhibitors with varying clinical uses and adverse effects.
- Ticlopidine adverse effects include aplastic anemia, neutropenia, and thrombotic thrombocytopenic purpura.
- Clopidogrel is used for secondary prevention of atherosclerotic events and acute coronary syndromes, with less myelotoxicity than ticlopidine.
- Prasugrel is used for acute coronary syndromes with percutaneous coronary intervention and has a more efficient platelet inhibition but increased bleeding risk compared to clopidogrel.
- Ticagrelor is a reversible inhibitor of the P2Y12 ADP receptor, used for acute coronary syndromes and percutaneous coronary intervention.
- GPIIb-IIIa antagonists like eptifibatide, abciximab, and tirofiban prevent binding of fibrinogen and other adhesion ligands.
- Eptifibatide is used for acute coronary syndromes and percutaneous coronary intervention, with major bleeding and thrombocytopenia as adverse effects.
- Abciximab is used as an adjunct to percutaneous coronary intervention to prevent acute cardiac ischemic complications, with thrombocytopenia and stroke as adverse effects.
- Tirofiban is used for acute coronary syndromes and has similar therapeutic considerations as eptifibatide, but is a nonpeptide tyrosine analogue.
- GPIIb-IIIa antagonists have specific contraindications and considerations, such as avoiding co-administration with a second antagonist and minimizing use in certain medical conditions.
Test your knowledge of anticoagulant and thrombolytic agents with this quiz. Explore indications, administration, adverse effects, and contraindications of drugs such as Apixaban, Rivaroxaban, Direct Thrombin Inhibitors, Argatroban, Dabigatran, Recombinant Activated Protein C, Streptokinase, and Recombinant Tissue Plasminogen Activator.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
